SPY305.66+0.11 0.04%
DIA256.32+1.05 0.41%
IXIC9,493.97-58.08 -0.61%

RBC Capital Maintains Outperform on Abeona Therapeutics, Lowers Price Target to $7

RBC Capital maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $11 to $7.

Benzinga · 05/08/2020 12:53

RBC Capital maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $11 to $7.